Cargando…
Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures
PURPOSE: New patient reported outcome (PRO) measures are regularly developed to assess various aspects of the patients’ perspective on their disease and treatment. For these instruments to be useful in clinical research, they must undergo a proper psychometric validation, including demonstration of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275948/ https://www.ncbi.nlm.nih.gov/pubmed/25492701 http://dx.doi.org/10.1186/s12955-014-0176-2 |
_version_ | 1782350198918348800 |
---|---|
author | Anthoine, Emmanuelle Moret, Leïla Regnault, Antoine Sébille, Véronique Hardouin, Jean-Benoit |
author_facet | Anthoine, Emmanuelle Moret, Leïla Regnault, Antoine Sébille, Véronique Hardouin, Jean-Benoit |
author_sort | Anthoine, Emmanuelle |
collection | PubMed |
description | PURPOSE: New patient reported outcome (PRO) measures are regularly developed to assess various aspects of the patients’ perspective on their disease and treatment. For these instruments to be useful in clinical research, they must undergo a proper psychometric validation, including demonstration of cross-sectional and longitudinal measurement properties. This quantitative evaluation requires a study to be conducted on an appropriate sample size. The aim of this research was to list and describe practices in PRO and proxy PRO primary psychometric validation studies, focusing primarily on the practices used to determine sample size. METHODS: A literature review of articles published in PubMed between January 2009 and September 2011 was conducted. Three selection criteria were applied including a search strategy, an article selection strategy, and data extraction. Agreements between authors were assessed, and practices of validation were described. RESULTS: Data were extracted from 114 relevant articles. Within these, sample size determination was low (9.6%, 11/114), and were reported as either an arbitrary minimum sample size (n = 2), a subject to item ratio (n = 4), or the method was not explicitly stated (n = 5). Very few articles (4%, 5/114) compared a posteriori their sample size to a subject to item ratio. Content validity, construct validity, criterion validity and internal consistency were the most frequently measurement properties assessed in the validation studies. Approximately 92% of the articles reported a subject to item ratio greater than or equal to 2, whereas 25% had a ratio greater than or equal to 20. About 90% of articles had a sample size greater than or equal to 100, whereas 7% had a sample size greater than or equal to 1000. CONCLUSIONS: The sample size determination for psychometric validation studies is rarely ever justified a priori. This emphasizes the lack of clear scientifically sound recommendations on this topic. Existing methods to determine the sample size needed to assess the various measurement properties of interest should be made more easily available. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-014-0176-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4275948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42759482014-12-25 Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures Anthoine, Emmanuelle Moret, Leïla Regnault, Antoine Sébille, Véronique Hardouin, Jean-Benoit Health Qual Life Outcomes Review PURPOSE: New patient reported outcome (PRO) measures are regularly developed to assess various aspects of the patients’ perspective on their disease and treatment. For these instruments to be useful in clinical research, they must undergo a proper psychometric validation, including demonstration of cross-sectional and longitudinal measurement properties. This quantitative evaluation requires a study to be conducted on an appropriate sample size. The aim of this research was to list and describe practices in PRO and proxy PRO primary psychometric validation studies, focusing primarily on the practices used to determine sample size. METHODS: A literature review of articles published in PubMed between January 2009 and September 2011 was conducted. Three selection criteria were applied including a search strategy, an article selection strategy, and data extraction. Agreements between authors were assessed, and practices of validation were described. RESULTS: Data were extracted from 114 relevant articles. Within these, sample size determination was low (9.6%, 11/114), and were reported as either an arbitrary minimum sample size (n = 2), a subject to item ratio (n = 4), or the method was not explicitly stated (n = 5). Very few articles (4%, 5/114) compared a posteriori their sample size to a subject to item ratio. Content validity, construct validity, criterion validity and internal consistency were the most frequently measurement properties assessed in the validation studies. Approximately 92% of the articles reported a subject to item ratio greater than or equal to 2, whereas 25% had a ratio greater than or equal to 20. About 90% of articles had a sample size greater than or equal to 100, whereas 7% had a sample size greater than or equal to 1000. CONCLUSIONS: The sample size determination for psychometric validation studies is rarely ever justified a priori. This emphasizes the lack of clear scientifically sound recommendations on this topic. Existing methods to determine the sample size needed to assess the various measurement properties of interest should be made more easily available. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-014-0176-2) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-09 /pmc/articles/PMC4275948/ /pubmed/25492701 http://dx.doi.org/10.1186/s12955-014-0176-2 Text en © Anthoine et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Anthoine, Emmanuelle Moret, Leïla Regnault, Antoine Sébille, Véronique Hardouin, Jean-Benoit Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title | Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title_full | Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title_fullStr | Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title_full_unstemmed | Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title_short | Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
title_sort | sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275948/ https://www.ncbi.nlm.nih.gov/pubmed/25492701 http://dx.doi.org/10.1186/s12955-014-0176-2 |
work_keys_str_mv | AT anthoineemmanuelle samplesizeusedtovalidateascaleareviewofpublicationsonnewlydevelopedpatientreportedoutcomesmeasures AT moretleila samplesizeusedtovalidateascaleareviewofpublicationsonnewlydevelopedpatientreportedoutcomesmeasures AT regnaultantoine samplesizeusedtovalidateascaleareviewofpublicationsonnewlydevelopedpatientreportedoutcomesmeasures AT sebilleveronique samplesizeusedtovalidateascaleareviewofpublicationsonnewlydevelopedpatientreportedoutcomesmeasures AT hardouinjeanbenoit samplesizeusedtovalidateascaleareviewofpublicationsonnewlydevelopedpatientreportedoutcomesmeasures |